Search all trials

Find therapies in clinical trials near you – page 791

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 101

3 961 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study of Boserolimab, MK-0482, and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer Resistant to PD-(L)1 Therapy

Registered drugNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:Boserolimab

Contact Research Centre

Malignant melanoma

Not recruiting

Registered drugNo placebo

Study on Patient Preference for Nivolumab and Relatlimab Administration Methods in Melanoma Patients

Registered drugNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Nivolumab

Contact Research Centre

Breast cancer+2

Not recruiting

Registered drugNo placebo

Study on Giredestrant and Fulvestrant with CDK4/6 Inhibitor for Patients with ER+ HER2-Negative Advanced Breast Cancer Resistant to Endocrine Therapy

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Abemaciclib

Contact Research Centre

Dyslipidaemia

Not recruiting

Investigational

Study on the Effects of AZD0780 on Cholesterol Levels in Adults Aged 18-75 with Dyslipidemia

Investigational

Czechia

Participants:18–64 years · 65+ years
Substances:1-[6-[[(1S,3S)-3-[[5-(Difluoromethoxy)Pyrimidin-2-Yl]Amino]Cyclopentyl]Amino]Pyridin-3-Yl]Pyridin-2-One

Contact Research Centre

Hypertension

Not recruiting

Registered drugNo placebo

Study on the Effects of Telmisartan, Amlodipine, and Hydrochlorothiazide on Blood Pressure in Patients with Hypertension

Registered drugNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:Amlodipine

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study Comparing SB27 and Pembrolizumab for Patients with Metastatic Non-Small Cell Lung Cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Neoplasm

Not recruiting

Registered drugNo placebo

Study of BMS-986288 and Nivolumab for Patients with Advanced Solid Tumors

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Bms-986288

Contact Research Centre

Phenylketonuria

Not recruiting

Registered drug

Study on the Effectiveness and Safety of SYNB1934 for Adults with Phenylketonuria (PKU)

Registered drug

Denmark

Participants:0–17 years · 18–64 years · 65+ years
Substances:Esomeprazole

Contact Research Centre

Study of Brentuximab Vedotin, Adriamycin, Vinblastine, and Dacarbazine for Children with Advanced Stage Hodgkin Lymphoma

Not recruiting

Registered drugNo placebo

Study of Brentuximab Vedotin, Adriamycin, Vinblastine, and Dacarbazine for Children with Advanced Stage Hodgkin Lymphoma

Registered drugNo placebo

Italy

Participants:0–17 years
Substances:Brentuximab Vedotin

Contact Research Centre

Psoriasis

Not recruiting

Registered drug

Study on Guselkumab and Etanercept for Treating Chronic Plaque Psoriasis in Children Aged 6 to 17 Years

Registered drug

Belgium

Participants:0–17 years
Substances:Etanercept

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study on Lorlatinib for Patients with ALK-Positive or ROS1-Positive Non-Small Cell Lung Cancer Continuing from Previous Studies

Registered drugNo placebo

France

Participants:18–64 years
Substances:Lorlatinib

Contact Research Centre

Deafness bilateral

Not recruiting

Registered drugNo placebo

Study on SENS-501 for Children with Severe Hearing Loss Due to Otoferlin Gene Mutations

Registered drugNo placebo

France

Participants:0–17 years
Substances:Abiraterone Acetate

Contact Research Centre

Find therapies in clinical trials near you – page 791

10 273 trials match your criteria

Non-small cell lung cancer

Study of Boserolimab, MK-0482, and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer Resistant to PD-(L)1 Therapy

Malignant melanoma

Study on Patient Preference for Nivolumab and Relatlimab Administration Methods in Melanoma Patients

Breast cancer+2

Study on Giredestrant and Fulvestrant with CDK4/6 Inhibitor for Patients with ER+ HER2-Negative Advanced Breast Cancer Resistant to Endocrine Therapy

Dyslipidaemia

Study on the Effects of AZD0780 on Cholesterol Levels in Adults Aged 18-75 with Dyslipidemia

Hypertension

Study on the Effects of Telmisartan, Amlodipine, and Hydrochlorothiazide on Blood Pressure in Patients with Hypertension

Non-small cell lung cancer

Study Comparing SB27 and Pembrolizumab for Patients with Metastatic Non-Small Cell Lung Cancer

Neoplasm

Study of BMS-986288 and Nivolumab for Patients with Advanced Solid Tumors

Phenylketonuria

Study on the Effectiveness and Safety of SYNB1934 for Adults with Phenylketonuria (PKU)

Study of Brentuximab Vedotin, Adriamycin, Vinblastine, and Dacarbazine for Children with Advanced Stage Hodgkin Lymphoma

Study of Brentuximab Vedotin, Adriamycin, Vinblastine, and Dacarbazine for Children with Advanced Stage Hodgkin Lymphoma

Psoriasis

Study on Guselkumab and Etanercept for Treating Chronic Plaque Psoriasis in Children Aged 6 to 17 Years

Non-small cell lung cancer

Study on Lorlatinib for Patients with ALK-Positive or ROS1-Positive Non-Small Cell Lung Cancer Continuing from Previous Studies

Deafness bilateral

Study on SENS-501 for Children with Severe Hearing Loss Due to Otoferlin Gene Mutations

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.